R. Castanon

The RADAR Study: Week 48 Safety and Efficacy of RAltegravir Combined with Boosted DARunavir Compared to Tenofovir/Emtricitabine Combined with Boosted Darunavir in Antiretroviral-Naive Patients. Impact on Bone Health

P. Tebas, N. Maalouf, Irfan M. Farukhi, 2014, PloS one.

Glioblastoma and Breast Cancer: Case Report

R. Castanon, A. Palomo, M. L. Flores, 2018 .

Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease

P. Tebas, N. Maalouf, Irfan M. Farukhi, 2016, AIDS.

The Differential Effects of Human Immunodeficiency Virus and Hepatitis C Virus on Bone Microarchitecture and Fracture Risk

B. Adams-Huet, P. Tebas, N. Maalouf, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Corrigendum to “Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy”

B. Adams-Huet, Katherine Neubecker, Irfan M. Farukhi, 2017, Journal of osteoporosis.